(R)-1-(3-Chloro-4-methylphenyl)ethanamine hydrochloride, 95.0%, 1g

2-Chloromethylquinoline hydrochloride, 97.0%, 5g

6-Phenylbenzo[d]thiazol-2-amine, 250mg

(1r)-1-(3-Bromo-5-fluorophenyl)ethan-1-ol, 98%, 250mg

GC capillary column ROTI®Cap-5, 50 m, 0.32 mm, 1.00 µm, 1 Piece(s)

(S)-2-Amino-3-(2-chlorophenyl)propanoic acid, 95.0%, 10g

3-MERCAPTOPHENYLBORONIC ACID, 98.0%, 5g

2-Methoxypyridine-4-boronic acid, 97.0%, 1g

1-(Perfluorohexyl)octane, 98%, 5g

ethyl 2-(4,6-difluoro-2-iminobenzo[d]thiazol-3(2H)-yl)acetate hydrobromide, 95.0%, 250mg

Benzyl Azide, Pract., 94.0%, 25g

(1S,4S)-2,5-Diazabicyclo[2.2.1]heptane dihydrobromide, 97%, 1g

(R)-2-(Benzylamino)-3-hydroxypropanoic acid, 95.0%, 5g